Andrew C. Agwunobi M.D. - Mar 1, 2022 Form 4 Insider Report for HUMANA INC (HUM)

Role
Seg. President, Home Solutions
Signature
Andrew C. Agwunobi, M.D.
Stock symbol
HUM
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/3/2022, 10:30 AM
Previous filing
Feb 22, 2022
Next filing
Dec 19, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 0 Mar 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Options Award $0 +3.09K $0.00 3.09K Mar 1, 2022 Humana Common 3.09K $430.62 Direct F1
transaction HUM Restricted Stock Units Award $0 +784 $0.00 784 Mar 1, 2022 Humana Common 784 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right to buy pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 3/1/2022, vesting in three annual increments from 3/1/23 to 3/1/25.
F2 Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
F3 Restricted stock units granted to reporting person on 3/1/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.